Tiziana Life Sciences Ltd(TLSA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
TLSA Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Tiziana Life Sciences Ltd (TLSA), a Healthcare sector company. TLSA is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Top institutional holders of TLSA by reported 13-F value include Dauntless Investment Group,, MARSHALL WACE, LLP, Zhang Financial, based on the most recent SEC filings. TLSA trades on the Nasdaq exchange and files with the SEC under CIK 1723069. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TLSA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tiziana Life Sciences Ltd directly from SEC EDGAR.
AI Insight: TLSA Financial Trends
No financial data available across all periods to assess TLSA's operational performance or financial trends.
• Complete absence of revenue, profitability, and cash flow data across all quarters from Q4 2018 through Q4 2024.
⚠ Lack of reported financial metrics raises questions about company's operational status and reporting compliance.
AI Insight: TLSA Ratio Trends
Financial ratio data is completely unavailable across all periods, preventing any meaningful trend analysis.
• No operating margin, profitability, or return metrics are available for any reported period.
⚠ Complete absence of financial ratio data raises questions about data availability or reporting quality.
Get alerted when TLSA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Tiziana Life Sciences Ltd including:
Top Institutional Holders of TLSA
Dauntless Investment Group, LLC
$2.5M2,165,231 shMARSHALL WACE, LLP
$184.4K157,566 shZhang Financial LLC
$130.9K111,900 shUBS Group AG
$112.0K95,700 shFocus Partners Wealth
$92.9K79,365 shGEODE CAPITAL MANAGEMENT, LLC
$91.5K78,204 shGOLDMAN SACHS GROUP INC
$88.5K75,660 shHSBC HOLDINGS PLC
$75.5K62,437 shMORGAN STANLEY
$61.0K52,156 shEWA, LLC
$53.8K45,948 sh
| Fund | Value | Shares |
|---|---|---|
| Dauntless Investment Group, LLC | $2.5M | 2,165,231 |
| MARSHALL WACE, LLP | $184.4K | 157,566 |
| Zhang Financial LLC | $130.9K | 111,900 |
| UBS Group AG | $112.0K | 95,700 |
| Focus Partners Wealth | $92.9K | 79,365 |
| GEODE CAPITAL MANAGEMENT, LLC | $91.5K | 78,204 |
| GOLDMAN SACHS GROUP INC | $88.5K | 75,660 |
| HSBC HOLDINGS PLC | $75.5K | 62,437 |
| MORGAN STANLEY | $61.0K | 52,156 |
| EWA, LLC | $53.8K | 45,948 |
More Healthcare Companies
View all Healthcare →Put TLSA on your watchlist
Track score changes the day Tiziana Life Sciences Ltd files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is TLSA a good stock to buy?
13F Pro's AI-powered analysis of Tiziana Life Sciences Ltd (TLSA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TLSA are available on the TLSA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own TLSA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TLSA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Tiziana Life Sciences Ltd's investment landscape.